Skip to content

OLFADOG BIOTECH

Active
Public limited companyfounded 20223 yrs activeDrève Richelle 161P, 1410 Waterloo, BelgiumKBO/BCE: BE 0794.892.333
Summary

OLFADOG BIOTECH has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.4m and a net result of -€188,738. Its solvency ranks better than 79% of 248 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.4% (very low).

Overview

Activity
Research and development on biotechnology
NACE 72101NACE 72110
1 site
Size
€1.8mtotal assets 2024
Equity
€1.4m
Loss
-€188,738
Financial health
85 Excellent Checked score 2024
Bankruptcy chance 12 m
0.4%
Structure
Largest shareholder
Natix · 19.98%
Accounts 67 d overdue0 of 2 deeds read
Why 85- Figures for FY 2024 (filed 10-07-2025)- Loss of €188,738, the second in a row (FY 2024)+ Sector Scientific research and development (NACE 72)+ Size: total assets €1.8mShow the evidence

Checked score

Score 2024
85 / 100
Excellent
Probability in this band: under 0.55%
Better than 68% of its sector peers (NACE 72, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2023
Strong
Solvency 100+19
equity 80.0% of total assets
Liquidity 88+41
short-term debt 20.0% · cash 35.1%
Profitability 6+6
return on assets -10.5%
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%

About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (934 companies)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%▲ +6.7% vs 11-2024 01-2025: 0.1%▼ -8.6% vs 12-2024 02-2025: 0.1%● 0.0% vs 01-2025 03-2025: 0.1%▲ +3.4% vs 02-2025 04-2025: 0.1%▲ +5.8% vs 03-2025 05-2025: 0.1%▲ +0.8% vs 04-2025 06-2025: 0.2%▲ +18.6% vs 05-2025 07-2025: 0.2%▲ +11.1% vs 06-2025 08-2025: 0.1%▼ -68.8% vs 07-2025lowest value 09-2025: 0.1%● 0.0% vs 08-2025lowest value 10-2025: 0.1%● 0.0% vs 09-2025lowest value 11-2025: 0.1%● 0.0% vs 10-2025lowest value 12-2025: 0.1%● 0.0% vs 11-2025lowest value 01-2026: 0.1%● 0.0% vs 12-2025lowest value 02-2026: 0.1%● 0.0% vs 01-2026lowest value 03-2026: 0.1%● 0.0% vs 02-2026lowest value 04-2026: 0.1%▲ +5.7% vs 03-2026 05-2026: 0.1%▲ +3.6% vs 04-2026 06-2026: 0.1%▲ +13.8% vs 05-2026 07-2026: 0.1%▲ +21.2% vs 06-2026 08-2026: 0.1%▲ +87.5% vs 07-2026 09-2026: 0.2%▲ +35.3% vs 08-2026 10-2026: 0.4%▲ +105% vs 09-2026highest value
  • Figures for FY 2024 (filed 10-07-2025) raises the probability
  • Sector Scientific research and development (NACE 72) lowers the probability
  • Loss of €188,738, the second in a row (FY 2024) raises the probability
  • Size: total assets €1.8m lowers the probability for this profile
Credit up to €120,000 at 30 days acceptable
Liquidity ample (current ratio 2.34 against 0.65 in 2023; short-term debt: 20% and cash: 35.1% of total assets), and 20% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 72, micro). Better than this share of them on solvency 83%, liquidity 76%, profitability 23%, growth against the median 89%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 06-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Figures for FY 2024 (filed 10-07-2025)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Sector Scientific research and development (NACE 72)
In the bankruptcy model this factor lowers the probability.
KBO
raises risk · Loss of €188,738, the second in a row (FY 2024)
In the bankruptcy model this factor raises the probability.
NBB · annual accounts
lowers risk · Size: total assets €1.8m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 09-07-2025, 22 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
not confirmed
2024
22 d early
2023
47 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 35 days before the deadline; the sector median for financial year 2024 is 13 days before the deadline, and 32% of the sector filed late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2024 · full…
  2. Liquidity quadruplescurrent ratio 2.34
  3. Equity above €1mEq €1.4m ▲70.8%

Key points

  • Positive: Equity rose in 2024from €844,571 to €1.4m ▲ 70.8% View
  • Caution: Accounts not fileddeadline was 31-07-2026 67 d late View
  • Total assets 20242 fiscal years filed €1.8m View

By topic

Financials

Fiscal year
2024
Total assets
€1.8m
Loss
-€188,738
Solvency
80.0%
Total assets▲ 19.0%
Net result
20232024
Go to Financials

Timeline

Events
4
Since
2024
  1. 09-07-2025Annual accounts filed
  2. 31-12-2024Liquidity quadruples
  3. 31-12-2024Equity above €1m
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Research and development on biotechnologyNACE 72101
Founded
16-12-2022
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.